OLVIG
AVNS icon

Oliver Lagore Vanvalin Investment Group’s Avanos Medical AVNS Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$115 Buy
+8
New +$101 ﹤0.01% 638
2024
Q4 		$127 Hold
8
– – ﹤0.01% 667
2024
Q3 		$192 Hold
8
– – ﹤0.01% 649
2024
Q2 		$159 Sell
8
-23
-74% -$448 ﹤0.01% 698
2024
Q1 		$617 Buy
31
+23
+288% +$445 ﹤0.01% 665
2023
Q4 		$179 Hold
8
– – ﹤0.01% 724
2023
Q3 		$162 Hold
8
– – ﹤0.01% 809
2023
Q2 		$204 Hold
8
– – ﹤0.01% 749
2023
Q1 		$238 Hold
8
– – ﹤0.01% 674
2022
Q4 		$216 Hold
8
– – ﹤0.01% 636
2022
Q3 		$0 Hold
8
– – ﹤0.01% 636
2022
Q2 		$0 Hold
8
– – ﹤0.01% 618
2022
Q1 		$0 Buy
+8
New +$258 ﹤0.01% 566

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's AVNS Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Avanos Medical (AVNS) in Q2 2025: 8 shares worth $115. The stake represents ﹤0.01% of the portfolio and ranks #638 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in AVNS as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in AVNS in Q1 2022 and has held it in 13 quarters since. The position peaked at $617 in Q1 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 8 shares of Avanos Medical worth $115 as of Q2 2025.
  • Avanos Medical was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Avanos Medical made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #638 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Avanos Medical in Q1 2022 and has held it in 13 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Avanos Medical position peaked at $617 in Q1 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.